Diagnostic imaging and biopsy use among elderly medicare beneficiaries with hepatocellular carcinoma

Journal of Oncology Practice

Volumn 7, Issue 3, 2011, Pages 155-160

  Massarweh, Nader N ^a,b   Park, James O ^a,b   Bruix, Jordi ^a,b   Yeung, Raymond S W ^a,b   Etzioni, Ruth B ^a,b   Symons, Rebecca Gaston ^a,b   Baldwin, Laura Mae ^a,b   Flum, David R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; ELDERLY CARE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; RISK FACTOR; SENSITIVITY ANALYSIS; TUMOR VOLUME;

EID: 80052718551     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2010.000116     Document Type: Article

References (22)

1. Colli A, Fraquelli M, Casazza G, et al: Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am J Gastroenterol 101:513-523, 2006 (Pubitemid 43340927)
2. Hayashi PH, Trotter JF, Forman L, et al: Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl 10:42-48, 2004 (Pubitemid 38885891)
3. Silva MA, Hegab B, Hyde C, et al: Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: A systematic review and metaanalysis. Gut 57:1592-1596, 2008
4. Saborido BP, Díaz JC, De Los Galanes SJ, et al: Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? Transplant Proc 37:3874-3877, 2005 (Pubitemid 43015197)
5. Young AL, Malik HZ, Abu-Hilal M, et al: Large hepatocellular carcinoma: Time to stop preoperative biopsy. J Am Coll Surg 205:453-462, 2007 (Pubitemid 47314300)
6. Bruix J, Sherman M, Llovet JM, et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430, 2001 (Pubitemid 32844200)
7. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/PDF/hepatobiliary. pdf
8. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 42:1208-1236, 2005 (Pubitemid 43112690)
9. The National Cancer Institute: Surveillance, Epidemiology, and End Results. http://seer.cancer.gov/
10. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl): IV-3-IV-18, 2002
11. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40(8 Suppl): IV-19-IV-25, 2002
12. Cooper GS, Virnig B, Klabunde CN, et al: Use of SEER-Medicare data for measuring cancer surgery. Med Care 40(8 Suppl): IV-43-IV-48, 2002
13. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000 (Pubitemid 32007842)
14. Ambler G, Omar RZ, Royston P: A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Stat Methods Med Res 16:277-298, 2007 (Pubitemid 47018663)
15. Bloom BS, De Pouvourville N, Chhatre S, et al: Breast cancer treatment in clinical practice compared to best evidence and practice guidelines. Br J Cancer 90:26-30, 2004 (Pubitemid 38174933)
16. Du XL, Key CR, Osborne C, et al: Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 138:90-97, 2003 (Pubitemid 36222495)
17. Singhal R, Rubenstein LV, Wang M, et al: Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system. J Gen Intern Med 23:575-580, 2008
18. Cronin DP, Harlan LC, Potosky AL, et al: Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101:2308-2318, 2006 (Pubitemid 44477559)
19. Yu HY, Madison RA, Setodji CM, et al: Quality of surveillance for stage I testis cancer in the community. J Clin Oncol 27:4327-4332, 2009
20. Schuster MA, McGlynn EA, Brook RH: How good is the quality of health care in the United States? Milbank Q 76:509, 517-563, 1998
21. Shaneyfelt TM: Building bridges to quality. JAMA 286:2600-2601, 2001
22. El-Serag HB, Siegel AB, Davila JA, et al: Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study. J Hepatol 44:158-166, 2006 (Pubitemid 41772530)